-Parties: The Appellants were AbbVie Corporation and AbbVie Biotechnology Ltd.; the Respondent was JAMP Pharma Corp. 

-Subject Matter: This Federal Court of Appeal matter (A-348-23) is an appeal (S.27 - Interloc.) under the Patent Act filed in Toronto on December 15, 2023, by AbbVie Corporation and AbbVie Biotechnology Ltd. against JAMP Pharma Corp. The appeal challenges a Federal Court decision in Court File Nos. T-561-21 and T-577-21 dated November 16, 2023. The case is ongoing. 

-Date: The hearing date had not yet been fixed; the court file notes that the file was sent to a Judicial Administrator and the hearing date and place were to be fixed.

-Venue: This was a federal case before the Federal Court of Appeal. 

-Amount: No financial award was specified.